当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析

鲁抗医药

(600789)

  

流通市值:74.23亿  总市值:86.33亿
流通股本:8.99亿   总股本:10.45亿

鲁抗医药(600789)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.57亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益531283.11万元,未分配利润119524.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产988310.50万元,负债457027.39万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,616,445,518.85,766,115,536.794,624,350,443.623,153,993,569.88
营业总成本1,540,488,548.055,618,182,381.984,428,403,914.862,972,941,889.51
其他经营收益
营业利润66,132,553.4160,572,041.23190,331,396.54146,923,738.32
利润总额66,739,069.62161,207,120.09186,336,080.99142,932,282.72
净利润56,534,399.6111,906,367.03146,619,239.95110,648,217.65
每股收益
其他综合收益-454,273.62-2,413,737.03-1,986,272.05-1,387,189.78
综合收益总额56,080,125.98109,492,630144,632,967.9109,261,027.87
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,826,535,675.54,950,854,868.243,814,446,929.583,916,634,147.39
非流动资产:
非流动资产合计5,056,569,310.575,083,196,201.075,001,920,232.854,970,728,841.83
资产总计9,883,104,986.0710,034,051,069.318,816,367,162.438,887,362,989.22
流动负债:
流动负债合计3,147,837,930.253,398,238,991.783,190,669,440.873,145,711,765.35
非流动负债:
非流动负债合计1,422,435,940.241,379,167,696.591,520,868,329.461,650,302,009.36
负债合计4,570,273,870.494,777,406,688.374,711,537,770.334,796,013,774.71
所有者权益(或股东权益):
归属于母公司股东权益合计5,167,566,195.435,114,660,477.083,957,023,996.463,944,150,813.15
股东权益合计5,312,831,115.585,256,644,380.944,104,829,392.14,091,349,214.51
负债和股东权益合计9,883,104,986.0710,034,051,069.318,816,367,162.438,887,362,989.22
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,313,555,180.855,270,386,648.733,901,835,418.372,631,087,931.49
经营活动现金流出小计1,149,432,101.544,572,212,799.713,595,892,858.792,318,750,652.91
经营活动产生的现金流量净额164,123,079.31698,173,849.02305,942,559.58312,337,278.58
投资活动产生的现金流量:
投资活动现金流入小计18,812,647.71105,391,311.2294,701,901.729,084,163.2
投资活动现金流出小计38,303,519.16338,862,954.47209,213,507.48134,413,489.79
投资活动产生的现金流量净额-19,490,871.45-233,471,643.25-114,511,605.78-105,329,326.59
筹资活动产生的现金流量:
筹资活动现金流入小计349,547,5003,162,149,719.171,349,991,458.24861,378,558.24
筹资活动现金流出小计712,037,353.372,006,638,977.911,495,642,130.78984,161,885.46
筹资活动产生的现金流量净额-362,489,853.371,155,510,741.26-145,650,672.54-122,783,327.22
汇率变动对现金及现金等价物的影响-5,283,354.812,244,815.34,725,522.795,177,073.16
现金及现金等价物净增加额-223,141,000.321,622,457,762.3350,505,804.0589,401,697.93
期末现金及现金等价物余额1,895,017,953.982,118,158,954.3546,206,996.02585,102,889.9
补充资料:
现金及现金等价物的净增加额-1,622,457,762.33-89,401,697.93
TOP↑